Cabaletta Bio, Inc Added to NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.69 USD | +13.00% | +5.05% | -44.10% |
05-15 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.10% | 612M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.02% | 22.27B | |
-12.64% | 22.22B | |
-5.29% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Cabaletta Bio, Inc.(NasdaqGS: CABA) added to NASDAQ Biotechnology Index